Compounding pharmacies occupy an unusual middle ground in the peptide world: legitimate, regulated, prescription-based, and yet distinct from the standard manufactured-drug pipeline. Here's how the process actually works.
What Compounding Actually Means
Compounding is the practice of a licensed pharmacist or physician combining, mixing, or altering ingredients to create a medication tailored to an individual patient, for example a different dose strength, a combination of two drugs in one injection, or a formulation for a patient who can't tolerate a commercial product's inactive ingredients. It's a long-standing, legal part of pharmacy practice, governed primarily by state boards of pharmacy alongside FDA oversight under sections 503A and 503B of the Federal Food, Drug, and Cosmetic Act.
Why Peptides Became a Compounding Flashpoint
When semaglutide and tirzepatide were in short supply, compounding pharmacies began producing versions using the same active pharmaceutical ingredient, which was legal under FDA drug-shortage provisions. Once the shortages officially ended, that legal basis narrowed significantly, and the FDA moved to restrict compounded copies of drugs no longer in shortage. Separately, some compounders began offering peptides that were never FDA-approved drugs at all, including BPC-157 and TB-500, which prompted the FDA to formally evaluate whether those substances should be eligible for compounding under 503A, ultimately determining they did not meet the criteria due to insufficient safety and manufacturing data.
The Supply Chain in Practice
A compounding pharmacy typically sources bulk active pharmaceutical ingredient from FDA-registered bulk drug substance facilities, tests it, and prepares the final product to order based on a prescription. Reputable 503A and 503B pharmacies operate under sterile compounding standards (USP 797/USP 795) and are subject to state board inspections. That's meaningfully different from a research chemical vendor shipping unregulated powder with a research-use-only disclaimer.
What to Watch For
Not every business calling itself a "compounding pharmacy" or "peptide clinic" is operating within this regulated framework. Some telehealth operations blur the line by prescribing compounded peptides that fall outside current FDA-permitted categories, or by using compounding language to market what is functionally a research chemical sale. Checking whether a pharmacy is licensed in your state and whether the specific peptide involved is actually on an FDA-permitted compounding list is a reasonable, concrete step before assuming a product is legitimate simply because a website uses clinical language.
State-by-State Variation
Compounding pharmacy oversight isn't purely federal. State boards of pharmacy license compounding pharmacies operating within their state, conduct inspections, and can take action independent of FDA enforcement. A pharmacy compliant with federal 503A rules still has to meet its home state's specific requirements, and enforcement intensity varies meaningfully from state to state. Checking a pharmacy's license status with the relevant state board is a concrete, publicly available way to verify legitimacy beyond whatever a company's own website claims.